Cargando…
Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734768/ https://www.ncbi.nlm.nih.gov/pubmed/36481838 http://dx.doi.org/10.1038/s41409-022-01894-1 |
| _version_ | 1784846639401271296 |
|---|---|
| author | Otiniano, Armelle van de Wyngaert, Zoe Brissot, Eolia Dulery, Rémy Gozlan, Joel Daguenel, Anne Abi Aad, Yasmine Ricard, Laure Stocker, Nicolas Banet, Anne Bonnin, Agnes Alsuliman, Tamim Marjanovic, Zora Schnuriger, Aurélie Coppo, Paul Legrand, Ollivier Lacombe, Karine Mohty, Mohamad Malard, Florent |
| author_facet | Otiniano, Armelle van de Wyngaert, Zoe Brissot, Eolia Dulery, Rémy Gozlan, Joel Daguenel, Anne Abi Aad, Yasmine Ricard, Laure Stocker, Nicolas Banet, Anne Bonnin, Agnes Alsuliman, Tamim Marjanovic, Zora Schnuriger, Aurélie Coppo, Paul Legrand, Ollivier Lacombe, Karine Mohty, Mohamad Malard, Florent |
| author_sort | Otiniano, Armelle |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9734768 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97347682022-12-12 Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases Otiniano, Armelle van de Wyngaert, Zoe Brissot, Eolia Dulery, Rémy Gozlan, Joel Daguenel, Anne Abi Aad, Yasmine Ricard, Laure Stocker, Nicolas Banet, Anne Bonnin, Agnes Alsuliman, Tamim Marjanovic, Zora Schnuriger, Aurélie Coppo, Paul Legrand, Ollivier Lacombe, Karine Mohty, Mohamad Malard, Florent Bone Marrow Transplant Correspondence Nature Publishing Group UK 2022-12-08 2023 /pmc/articles/PMC9734768/ /pubmed/36481838 http://dx.doi.org/10.1038/s41409-022-01894-1 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Otiniano, Armelle van de Wyngaert, Zoe Brissot, Eolia Dulery, Rémy Gozlan, Joel Daguenel, Anne Abi Aad, Yasmine Ricard, Laure Stocker, Nicolas Banet, Anne Bonnin, Agnes Alsuliman, Tamim Marjanovic, Zora Schnuriger, Aurélie Coppo, Paul Legrand, Ollivier Lacombe, Karine Mohty, Mohamad Malard, Florent Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases |
| title | Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases |
| title_full | Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases |
| title_fullStr | Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases |
| title_full_unstemmed | Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases |
| title_short | Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases |
| title_sort | tixagevimab/cilgavimab for omicron sars-cov-2 infection in patients with haematologic diseases |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734768/ https://www.ncbi.nlm.nih.gov/pubmed/36481838 http://dx.doi.org/10.1038/s41409-022-01894-1 |
| work_keys_str_mv | AT otinianoarmelle tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT vandewyngaertzoe tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT brissoteolia tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT duleryremy tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT gozlanjoel tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT daguenelanne tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT abiaadyasmine tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT ricardlaure tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT stockernicolas tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT banetanne tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT bonninagnes tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT alsulimantamim tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT marjanoviczora tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT schnurigeraurelie tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT coppopaul tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT legrandollivier tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT lacombekarine tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT mohtymohamad tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases AT malardflorent tixagevimabcilgavimabforomicronsarscov2infectioninpatientswithhaematologicdiseases |